$2.120
-0.039 (-1.85%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GRCE por análisis de gráficos similares
Alphio's GRCE stock price prediction model matches the current Grace Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.12 (-0.10%). The 1-week path is $2.08 (-1.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Grace Therapeutics, Inc?
Grace Therapeutics, Inc. (GRCE) is currently not a strong buy. The stock is priced at $2.12, significantly below its analyst price targets of $4 and $8, indicating potential upside. However, the company has faced recent challenges, including a 49% drop in stock price due to an FDA rejection of its drug application, which poses a significant risk. The current RSI of 39.7 suggests the stock is nearing oversold territory, but the negative sentiment from the FDA rejection and the projected net loss of $15.79 million in Q1 2027 raises concerns about immediate investment viability.
GRCE cerró en $2.12 el Friday, tras bajar -1.85%
Grace Therapeutics, Inc (GRCE) last closed at $2.12, losing -1.85%. These facts feed the 1-day and 1-week GRCE price prediction above.
Factores de la previsión
Los factores de la previsión de Grace Therapeutics, Inc (GRCE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GRCE, ordenadas por similitud.
Análisis de estacionalidad de GRCE
Historically the probability of a positive August return for GRCE is 0.00%. March offers the highest probability of a positive month at 66.67%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GRCE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $3.47 | $4.06 | $4.67 | +91.38% |
| Sep 2026 | $2.90 | $3.48 | $3.61 | +63.97% |
| Oct 2026 | $3.40 | $3.61 | $4.18 | +70.43% |
| Nov 2026 | $3.02 | $3.33 | $3.80 | +56.89% |
| Dec 2026 | $2.55 | $3.00 | $3.03 | +41.45% |
En 2026, se proyecta que Grace Therapeutics, Inc (GRCE) oscile entre $2.55 y $4.67.
Previsión mensual de Grace Therapeutics, Inc para 2026
En Aug de 2026, se proyecta que Grace Therapeutics, Inc promedie $4.06, con un mínimo de $3.47 y un máximo de $4.67.
En Sep de 2026, se proyecta que Grace Therapeutics, Inc promedie $3.48, con un mínimo de $2.90 y un máximo de $3.61.
En Oct de 2026, se proyecta que Grace Therapeutics, Inc promedie $3.61, con un mínimo de $3.40 y un máximo de $4.18.
En Nov de 2026, se proyecta que Grace Therapeutics, Inc promedie $3.33, con un mínimo de $3.02 y un máximo de $3.80.
En Dec de 2026, se proyecta que Grace Therapeutics, Inc promedie $3.00, con un mínimo de $2.55 y un máximo de $3.03.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.